ID
29931
Beschrijving
Study ID: 102123 Clinical Study ID: FFR102123 Study Title: A randomised double-blind placebo controlled parallel group multicentre long term study to evaluate the safety of once-daily, intranasal administration of GW685698X aqueous nasal spray 100mcg* for 52 weeks in adult and adolescent subjects with perennial allergic rhinitis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: FLUTIDE, Allermist, Veramyst, FLUNASE, FLIXOTAIDE, FLUTAIDE, FLIXOVATE, Avamys; Veramyst, Avamys, Allermist Study Indication: Rhinitis, Allergic, Perennial This ODM-file contains Repeat 12-lead-ECG.
Trefwoorden
Versies (1)
- 27-04-18 27-04-18 - Sarah Riepenhausen
Houder van rechten
GlaxoSmithKline
Geüploaded op
27 april 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety of once-daily administration of Fluticasone nasal spray in adults and adolescents with perennial allergic rhinitis GSK 102123
Repeat 12-lead-ECG
- StudyEvent: ODM
Similar models
Repeat 12-lead-ECG
- StudyEvent: ODM
C0205341 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])